Literature DB >> 8711794

Autonomic neuropathy predicts the development of stroke in patients with non-insulin-dependent diabetes mellitus.

J P Töyry1, L K Niskanen, E A Länsimies, K P Partanen, M I Uusitupa.   

Abstract

BACKGROUND AND
PURPOSE: Our aim was to determine the predictive factors for stroke in patients with non-insulin-dependent diabetes mellitus (NIDDM).
METHODS: We studied 133 patients with NIDDM at the time of diagnosis and 5 and 10 years later.
RESULTS: The number of new fatal or nonfatal strokes was 19 (14.7%; 14 after 5-year examination). High initial fasting blood glucose (odds ratio [OR], 1.2; 95% confidence interval [CI], 1.04 to 1.4) and the use of beta-blocking agents (OR, 6.7; 95% CI, 2.1 to 21.5) at baseline and the presence of parasympathetic neuropathy (OR, 6.7; 95% CI, 1.5 to 29.9), or sympathetic autonomic nervous dysfunction (OR, 1.1; 95% CI, 1.01 to 1.2), hypertriglyceridemia (OR, 5.7; 95% CI, 1.1 to 31.0), or use of beta-blocking agents (OR, 6.4; 95% CI, 1.3 to 31.2), and high fasting plasma glucose (OR, 1.2; 95% CI, 1.0 to 1.5) determined at 5-year examination predicted the development of stroke.
CONCLUSIONS: Autonomic neuropathy is an independent risk factor for stroke in NIDDM.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8711794     DOI: 10.1161/01.str.27.8.1316

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  16 in total

1.  Altered cerebral regulation in type 2 diabetic patients with cardiac autonomic neuropathy.

Authors:  H Marthol; C M Brown; U Zikeli; D Ziegler; N Dimitrov; R Baltadzhieva; M J Hilz
Journal:  Diabetologia       Date:  2006-08-29       Impact factor: 10.122

2.  Cardiovagal autonomic function in HIV-infected patients with unsuppressed HIV viremia.

Authors:  Dominic C Chow; Robert Wood; Julia Choi; Andrew Grandinetti; Mariana Gerschenson; Narin Sriratanaviriyakul; Beau Nakamoto; Cecilia Shikuma; Phillip Low
Journal:  HIV Clin Trials       Date:  2011 May-Jun

Review 3.  Cardiovascular complications in patients with autonomic failure.

Authors:  Valeria Milazzo; Cristina Di Stefano; Alberto Milan; Agnese Ravera; Gabriele Sobrero; Luca Sabia; Franco Veglio; Simona Maule
Journal:  Clin Auton Res       Date:  2015-03-20       Impact factor: 4.435

Review 4.  Advances in diabetes for the millennium: new treatments for diabetic neuropathies.

Authors:  Aaron I Vinik
Journal:  MedGenMed       Date:  2004-08-17

Review 5.  Cardiac autonomic neuropathy in patients with diabetes mellitus.

Authors:  Gerasimos Dimitropoulos; Abd A Tahrani; Martin J Stevens
Journal:  World J Diabetes       Date:  2014-02-15

Review 6.  Diabetic neuropathy: clinical features, etiology, and therapy.

Authors:  David Podwall; Clifton Gooch
Journal:  Curr Neurol Neurosci Rep       Date:  2004-01       Impact factor: 5.081

7.  A simple deep breathing test reveals altered cerebral autoregulation in type 2 diabetic patients.

Authors:  C M Brown; H Marthol; U Zikeli; D Ziegler; M J Hilz
Journal:  Diabetologia       Date:  2008-02-29       Impact factor: 10.122

8.  The evolving natural history of neurophysiologic function in patients with well-controlled diabetes.

Authors:  Christopher H Gibbons; Roy Freeman; Francisco Tecilazich; Thanh Dinh; Thomas E Lyons; Charalambos Gnardellis; Aristidis Veves
Journal:  J Peripher Nerv Syst       Date:  2013-06       Impact factor: 3.494

9.  Decreased heart rate variability may predict the progression of carotid atherosclerosis in type 2 diabetes.

Authors:  Anders Gottsäter; Asa Rydén Ahlgren; Soumia Taimour; Göran Sundkvist
Journal:  Clin Auton Res       Date:  2006-05-12       Impact factor: 5.625

Review 10.  Targeting Common Signaling Pathways for the Treatment of Stroke and Alzheimer's: a Comprehensive Review.

Authors:  Sedigheh Eskandari; Soraya Sajadimajd; Loghman Alaei; Zhaleh Soheilikhah; Hossein Derakhshankhah; Gholamreza Bahrami
Journal:  Neurotox Res       Date:  2021-06-25       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.